Recurrent Adult Acute Lymphoblastic Leukemia: Clinical Trials

2 trials for Recurrent Adult Acute Lymphoblastic Leukemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 32Completed 2

Follow Recurrent Adult Acute Lymphoblastic Leukemia: new trials by email Literature Review of Recurrent Adult Acute Lymphoblastic Leukemia trials Research Report on Recurrent Adult Acute Lymphoblastic Leukemia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease
prednisone, methylprednisolone, questionnaire administration - Graft Versus Host Disease, Recurrent Adult Acute Lymphoblastic Leukemia
Phase 3CompletedFred Hutchinson Cancer Center1642009-06-012017-08-21
Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late Complications
internet-based intervention, questionnaire administration, psychosocial assessment and care - Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Phase 3CompletedFred Hutchinson Cancer Research Center/University of Washington Cancer Consortium13372008-08-012012-03-07

Narrower conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Blast Crisis (1)  ·  Burkitt Lymphoma (1)  ·  Congenital Abnormalities (1)  ·  Depression (1)  ·  Fatigue (1)  ·  Graft vs Host Disease (1)  ·  Hodgkin Disease (1)  ·  Leukemia, Hairy Cell (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Leukemia, Myeloid, Accelerated Phase (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (1)  ·  Leukemia, Myeloid, Chronic-Phase (1)  ·  Leukemia, Myelomonocytic, Chronic (1)

Broader conditions

Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Immunoproliferative Disorders (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Lymphatic Diseases (2)  ·  Lymphoproliferative Disorders (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Behavior (1)  ·  Behavioral Symptoms (1)  ·  Blood Protein Disorders (1)  ·  Bone Marrow Diseases (1)  ·  Carcinogenesis (1)

Interventions

Counseling (1)  ·  Methylprednisolone (1)  ·  Methylprednisolone Acetate (1)  ·  Methylprednisolone Hemisuccinate (1)  ·  Prednisone (1)  ·  Psychiatric Rehabilitation (1)  ·  Therapeutics (1)

Sponsors

Fred Hutchinson Cancer Center (1)  ·  Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium (1)

Countries

United States (2)

Top investigators

Karen Syrjala (1)  ·  Marco Mielcarek (1)

Results publications

PMID 32628342, PMID 33420905, PMID 36282798

NIH funding

P01CA018029 (1), R01CA112631 (1)